Gain Therapeutics Stock Options
| GANX Stock | USD 2.18 0.10 4.39% |
Gain Therapeutics' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 2.36. The Gain Therapeutics option chain provides detailed quote and price information for the current Gain Therapeutics option contracts. It shows all of Gain Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Gain Therapeutics
Analyzing Gain Therapeutics' in-the-money options over time can help investors to take a profitable long position in Gain Therapeutics regardless of its overall volatility. This is especially true when Gain Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Gain Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Gain Therapeutics' stock while costing only a fraction of its price.
Gain Therapeutics In The Money Call Balance
When Gain Therapeutics' strike price is surpassing the current stock price, the option contract against Gain Therapeutics stock is said to be in the money. When it comes to buying Gain Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Gain Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Gain Current Options Market Mood
Gain Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Gain Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Gain Therapeutics' options investors are not very successful. Gain Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Gain contract
Base on the Rule 16, the options market is currently suggesting that Gain Therapeutics will have an average daily up or down price movement of about 0.15% per day over the life of the 2025-03-21 option contract. With Gain Therapeutics trading at USD 2.18, that is roughly USD 0.003216. If you think that the market is fully incorporating Gain Therapeutics' daily price movement you should consider buying Gain Therapeutics options at the current volatility level of 2.36%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Gain |
Purchasing Gain Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Gain calls. Remember, the seller must deliver Gain Therapeutics stock to the call owner when a call is exercised.
Gain Therapeutics Option Chain
When Gain Therapeutics' strike price is surpassing the current stock price, the option contract against Gain Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Gain Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Gain. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Gain. It also shows strike prices and maturity days for a Gain Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | GANX250321C00001000 | 0 | 1.0 | 0.0 - 5.0 | 5.0 | In |
Call | GANX250321C00002000 | 0 | 2.0 | 0.0 - 4.4 | 4.4 | In |
Call | GANX250321C00003000 | 11 | 3.0 | 0.0 - 0.15 | 0.5 | Out |
Call | GANX250321C00004000 | 0 | 4.0 | 0.0 - 0.7 | 0.7 | |
Call | GANX250321C00005000 | 0 | 5.0 | 0.0 - 0.75 | 0.75 | |
Put | GANX250321P00001000 | 0 | 1.0 | 0.0 - 0.75 | 0.75 | |
Put | GANX250321P00002000 | 0 | 2.0 | 0.0 - 3.1 | 3.1 | |
Put | GANX250321P00003000 | 0 | 3.0 | 0.0 - 3.5 | 3.5 | In |
Put | GANX250321P00004000 | 0 | 4.0 | 0.8 - 4.1 | 0.8 | In |
Put | GANX250321P00005000 | 0 | 5.0 | 2.4 - 3.4 | 2.4 | In |
Gain Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Gain Other Stockholder Equity
Other Stockholder Equity |
|
Gain Therapeutics Corporate Management
| Gianluca Fuggetta | Principal Reporting | Profile | |
| Xavier Barril | Chief Officer | Profile | |
| Joanne Taylor | Senior Research | Profile | |
| Terenzio PharmD | Senior Operations | Profile | |
| Salvatore Calabrese | CFO Sec | Profile |
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.